Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth

Completed · Not applicable

Conditions studied: Opioid Use Disorder

In brief

The primary aim of this study is to measure and explain the impact on long-term opioid use when medication-assisted treatment (MAT) is bundled with an evidence-based mobile-health system (A-CHESS).

Key facts

Study ID

NCT02712034

Run by

University of Wisconsin, Madison

People needed

417

Starts

2016-04-21

Expected to finish

2020-04-08

Last updated by the study team

2020-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• are 18+ years old;
• meet criteria for opioid use disorders of at least moderate severity (4 or 5 DSM-V criteria);
• Are currently taking medication-assisted treatment (MAT) as part of their standard clinical care;
• have no acute medical problem requiring immediate inpatient treatment;
• have no history of psychotic disorders, though those with other co-morbid psychopathology (mood disorders, anxiety, other substance use disorders) will be eligible;
• are willing to participate in a randomized clinical trial;
• provide the name, verified telephone number, and address of at least 2 contacts willing to help locate the patient, if necessary, during follow-up;
• are able to read and write in English;
• are not pregnant;
• are willing to share health-related data with primary care clinicians; and
• are, at study intake, abstinent from opioids for at least 1 week and no longer than 2 months, except for medications used to treat the disorder (e.g., methadone).

Where it is running

• Access Community Health Centers — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.